SRRK Q3 2024 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$446,000

Operating Income

-$65M

Net Income

-$64M

EPS (Diluted)

$-0.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$179M

Total Liabilities

$100M

Stockholders' Equity

$79M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$446,000	-$708,000	+37.0%
Operating Income	-$65M	-$44M	-48.3%
Net Income	-$64M	-$42M	-52.2%